Xiaoying Xue

13PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersEnvironmental biogeochemistryCancer therapy (excl. chemotherapy and radiation therapy)Planning and decision makingImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 04, 2026
Study on the expression, prognostic value, and molecular mechanisms of TIMP1 in glioma.

|Sep 01, 2026
Association between disease awareness and prognosis in patients with glioblastoma: A retrospective cohort study.

|Jul 14, 2026
Micro- and nanoplastic exposure and cancer: current evidence, mechanistic pathways, and translational challenges.

|Jun 12, 2026
Grade-Dependent Prognostic Value of Classical Clinicopathological Factors in Glioma: A Single-Center Retrospective Study.

|May 27, 2026
SMC3 Is Highly Expressed in Gliomas and Is Associated With Favorable Prognosis and B Cell-Related Immune Features.

|May 16, 2026
Multi-Omic Analysis of Glioma Identifies RRM2 as a Prognostic Biomarker Associated With Tumor Stemness and Cell Cycle-Related Pathways.

Pageof 3

Frequent Collaborators

10 joint publications

Huandi Zhou

4 joint publications

Liubing Hou

2 joint publications

Guohui Wang

2 joint publications

Zizhou Zhang